East Brunswick Pharmaceutical Litigation Lawyer

Drug Recalls - Defective Drugs - Dangerous Drugs

Toll Free: 1.866.NJLAWFIRM

Located in East Brunswick, the pharmaceutical litigation lawyers at Tortoreti, Tomes & Callahan, P.C. represent men, women, and children throughout New Jersey who were injured or killed by a dangerous or defective drug.

Bextra

Bextra was a popular painkiller used by millions for painful arthritis and other types of pain. Bextra has been linked to deaths, heart attacks, strokes and Stevens Johnson Syndrome, a painful skin rash. The risk factor for heart attack, stroke, and death may be even greater than Vioxx. On April 7, the FDA requested that Pfizer suspend sales of Bextra due to these serious risk factors. If you or a loved one took Bextra and suffered a heart attack, stroke or Stevens Johnson Syndrome, you may be entitled to compensation. Please contact us for a free consultation.

Heparin

On December 8, 2006, Baxter International Inc., the manufacturer of Heparin (Generic: along with the FDA informed doctors that the drug might be linked to thrombosis or blood clots in patients several weeks after they stop taking it. Heparin is an anticoagulant, also referred to as a blood thinner. Heparin prevents clot formation and halts clots from becoming larger, it does not thin the blood or dissolve clots that have already formed. Heparin is generally administered intravenously to thin a patient’s blood when there is a danger of clotting.

The FDA said it revised the warnings section of the prescribing information for Heparin, because of the possibility of delayed onset of thrombocytopenia and thrombosis. The FDA explained that as a “serious antibody-mediated reaction resulting from irreversible aggregation of platelets.” “Thrombotic events may be the initial presentation for heparin-induced thrombocytopenia and thrombosis which can transpire up to several weeks after the discontinuation of heparin therapy,” the FDA said.

Additionally, the prescribing information for Heparin also contains warnings that the drug can cause pulmonary embolism, cerebral blood clots, strokes, skin necrosis, and gangrene in arms and legs that could lead to amputation and possible death.

For more information see http://www.heparinfacts.com/.

If you or a loved one recently stopped taking Heparin and you suffered blood clots or any other injury, contact us for a free evaluation. Please feel free to contact us for a free consultation.

Heparin Baxter Recall

On January 17, 2008 Baxter Healthcare Corporation began recalling lots of heparin sodium injection as a precautionary measure due to an increase in the number of adverse reactions that may be associated with it. The lots have been reported to contain a contaminant.

Heparin is a prescription blood thinner used for hemodialysis, cardiac invasive procedures, orthopedic surgeries and other surgical procedures as well as treatment of other serious medical conditions such as deep venous thrombosis and pulmonary emboli.

The contaminated lots may be connected to as many as 19 deaths and 785 serious illnesses according to the Food and Drug Administration, although Baxter disputes that number. For further information, see the FDA Recall Press Release and the FDA Drug Safety Podcast.

Tortoreti, Tomes & Calllahan, PC are handling these claims. If you or a loved one were injured as a result of a contaminated heparin product, please contact us.

Ortho Evra Birth Control Patch

The Food and Drug Administration warned users of the Ortho Evra Birth Control patch that they are being exposed to more hormones and are at a higher risk of blood clots, strokes and other serious side effects, than previously disclosed. Manufacturer Ortho McNeil had maintained the patch was expected to be associated with similar risks as the pill. However, a new warning was added to the patch in mid-November 2005 that says women using the patch will be exposed to about 60% more estrogen than those using typical birth control pills. This is due to the hormones going directly to the bloodstream, rather than being swallowed and digested first

Reports have indicated that users die and suffer blood clots at a rate three times higher than women taking the pill. More than 4 million women have used the patch since it went on sale in 2002. Several lawsuits have been filed by families of women who died or suffered blood clots which using the patch.

If you or a loved one have been injured as a result of the Ortho Evra Birth Control Patch and would like further information, please contact us for a free consultation.

Tenacious - Trustworthy - Compassionate
Our Attorneys Have Aggressively Pursued Claims for the Injured
Since 1975

Tortoreti, Tomes & Callahan, P.C.
Attorneys at Law
Map
Tel: 732.257.9100
Toll Free: 1.866.NJLAWFIRM
Email